EUVIMEDEUVIMED entdecken
Crossref

Plasmonic Photoenzymatic Therapy with SERS Monitoring for Oral Cancer

M Zhao iD, H Shi, W Jiang, L Wang, S Wen, S Bao, K Hu, R Shi, W Song iD

Journal of Dental Research · 28.10.2026

DOI: 10.1177/00220345261490528 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Dental Research, online erschienen am 28.10.2026. Verfasst von M Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, Jilin, China. Die Arbeit nennt 27 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Traditional photodynamic therapy (PDT), chemodynamic therapy (CDT), and photothermal therapy (PTT) for oral squamous cell carcinoma (OSCC) face inherent limitations, including oxygen dependence, insufficient endogenous H 2 O 2 , and nonspecific thermal diffusion. To address these challenges, we developed a near infrared (NIR) responsive theranostic platform based on Au@RCDs@GOx. This system leverages a single NIR wavelength to trigger plasmon enhanced cascade therapy integrating PTT ablation, glucose oxidase (GOx) generated H 2 O 2 , photo amplified CDT, and starvation therapy. Importantly, photoexcited electrons are injected into the flavin adenine dinucleotide (FAD) cofactor of GOx via the red emitting carbon dots (RCD) shell, enabling sustained reactive oxygen species (ROS) generation even under glucose deprived conditions through direct 1-electron reduction of O 2 to superoxide anions (·O 2 − ). Meanwhile, Au@RCDs@GOx exhibit excellent surface-enhanced Raman scattering (SERS) activity, providing real-time feedback on oxidative stress within the tumor microenvironment. In an OSCC xenograft model, intratumoral administration of this platform at an ultralow dose (0.12 mg kg −1 ) achieved 95.7% tumor suppression with excellent biosafety. This work establishes photoenzymatic catalysis as an adaptive and synergistic paradigm for cancer therapy with integrated SERS monitoring.

Schlagwörter

Stichwörter der Autor:innen

Raman Spectroscopychemotherapyenzymologyflavin-adenine dinucleotideoral squamous cell carcinomaphotochemotherapy

Autor:innen und Institutionen

  • State Key Laboratory of Supramolecular Structure and Materials, College of Chemistry, Jilin University, Changchun, Jilin, China.
  • Department of Orthodontics, School and Hospital of Stomatology, Jilin University, Changchun, Jilin, China.
  • Jilin Provincial Key Laboratory of Tooth Development and Bone Remodeling, Changchun, Jilin, China.
  • Functional Polymer Materials R&D and Engineering Application Technology Innovation Center of Hebei, College of Chemical Engineering and Biotechnology, Xingtai University, Xingtai, Hebei, China.
  • Department of Vascular Surgery, China-Japan Union Hospital, Jilin University, Changchun, Jilin, China.

ORCID-Profile: M Zhao, W Song

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, M., Shi, H., Jiang, W., Wang, L., Wen, S., Bao, S., Hu, K., Shi, R., & Song, W. (2026). Plasmonic Photoenzymatic Therapy with SERS Monitoring for Oral Cancer. Journal of Dental Research. https://doi.org/10.1177/00220345261490528

Vancouver

Zhao M, Shi H, Jiang W, Wang L, Wen S, Bao S, et al. Plasmonic Photoenzymatic Therapy with SERS Monitoring for Oral Cancer. Journal of Dental Research. 2026. doi:10.1177/00220345261490528

BibTeX
@article{Zhao2026,
  author = {Zhao, M and Shi, H and Jiang, W and Wang, L and Wen, S and Bao, S and Hu, K and Shi, R and Song, W},
  title = {Plasmonic Photoenzymatic Therapy with SERS Monitoring for Oral Cancer},
  journal = {Journal of Dental Research},
  year = {2026},
  doi = {10.1177/00220345261490528}
}
Kostenlos starten →